These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21709418)

  • 1. Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands.
    Thorpe AJ; Clair A; Hochman S; Clemens S
    Eur Neurol; 2011; 66(1):18-29. PubMed ID: 21709418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome and periodic limb movements.
    Vetrugno R; Provini F; Montagna P
    Rev Neurol Dis; 2006; 3(2):61-70. PubMed ID: 16820753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and novel treatment approaches in restless legs syndrome: II. Treatment].
    Hirata K; Suzuki K
    Brain Nerve; 2013 Nov; 65(11):1391-9. PubMed ID: 24200617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The restless legs syndrome.
    Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I
    Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and novel treatment approaches in restless legs syndrome: I. Pathophysiology and diagnosis].
    Hirata K; Suzuki K
    Brain Nerve; 2013 Oct; 65(10):1185-97. PubMed ID: 24101430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
    Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
    Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome: detection and management in primary care. National Heart, Lung, and Blood Institute Working Group on Restless Legs Syndrome.
    Am Fam Physician; 2000 Jul; 62(1):108-14. PubMed ID: 10905782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome in 2004.
    Sonka K; Kemlink D
    Prague Med Rep; 2004; 105(4):337-56. PubMed ID: 15822631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep-related movement disorders.
    Silber MH
    Continuum (Minneap Minn); 2013 Feb; 19(1 Sleep Disorders):170-84. PubMed ID: 23385700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease.
    Sun YM; Hoang T; Neubauer JA; Walters AS
    J Neurol Sci; 2011 May; 304(1-2):93-101. PubMed ID: 21376342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.